Latest News & Features
article
Blank Rome has brought in patent agent Joseph Jackson to the firm’s IP and Technology practice group in Houston. 26 January 2023
Big Pharma
US pharma giant says competitor’s drug Imjudo violates two patents | BMS’ blockbuster was first to use checkpoint inhibitors, says complaint. 26 January 2023
Generics
Commission holds that the convicted former pharma head may have violated his life-long ban from working in the life sciences industry | Shkreli is already convicted of conspiring to illegally increase the price of a life-saving drug. 24 January 2023
article
New study examines industry by product, application and region | China, Germany and India predicted to see the largest growth. 24 January 2023
Generics
UK-based cannabidiol lab sues firms behind proposed ANDA | Feud centres on a cannabis treatment for epilepsy. 19 January 2023
Biotechnology
Cohausz & Florack has added two new partners to the team to further expand the firm’s IP expertise in key technical areas. 19 January 2023
Biotechnology
Leader of Brown Rudnik’s IP practice moves to US office of London firm | Boston office continues growth. 12 January 2023
article
Dispute concerns two of the cosmetic giant’s best-selling brands | Arguments revolved around whether the French company could be sued in the US. 12 January 2023
Big Pharma
Clarivate study highlights treatments with blockbuster potential | IV, Parkinson’s disease, Crohn’s disease, alopecia, multiple myeloma and breast cancer make the list | Nine blockbusters from China also predicted. 12 January 2023
Americas
Subsidiary held that its arguments were same as those cited in the much-anticipated Amgen v Sanofi | Dispute concerns a cancer treatment used to treat B-cell lymphoma. 10 January 2023